Beijing Wandong Medical Technology Co Ltd
SSE:600055
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Wandong Medical Technology Co Ltd
SSE:600055
|
CN |
Balance Sheet
Balance Sheet Decomposition
Beijing Wandong Medical Technology Co Ltd
Beijing Wandong Medical Technology Co Ltd
Balance Sheet
Beijing Wandong Medical Technology Co Ltd
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
85
|
139
|
149
|
131
|
181
|
151
|
143
|
259
|
259
|
226
|
213
|
257
|
189
|
193
|
102
|
751
|
467
|
274
|
463
|
684
|
863
|
3 231
|
3 415
|
3 552
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
863
|
3 231
|
3 415
|
3 552
|
|
| Cash Equivalents |
85
|
139
|
149
|
131
|
181
|
151
|
143
|
259
|
259
|
226
|
213
|
257
|
189
|
193
|
102
|
751
|
467
|
274
|
463
|
683
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
255
|
345
|
347
|
234
|
450
|
246
|
100
|
4
|
0
|
|
| Total Receivables |
41
|
55
|
78
|
131
|
111
|
123
|
201
|
216
|
193
|
229
|
236
|
332
|
261
|
234
|
235
|
399
|
514
|
542
|
536
|
425
|
489
|
583
|
547
|
623
|
|
| Accounts Receivables |
26
|
46
|
72
|
118
|
93
|
107
|
176
|
191
|
170
|
198
|
207
|
287
|
215
|
207
|
188
|
167
|
295
|
286
|
259
|
156
|
202
|
313
|
270
|
383
|
|
| Other Receivables |
16
|
9
|
6
|
13
|
18
|
17
|
25
|
25
|
23
|
31
|
29
|
45
|
46
|
26
|
47
|
232
|
219
|
256
|
278
|
270
|
287
|
270
|
277
|
240
|
|
| Inventory |
144
|
169
|
185
|
215
|
231
|
208
|
198
|
174
|
169
|
207
|
214
|
256
|
212
|
192
|
182
|
135
|
175
|
192
|
188
|
246
|
192
|
267
|
378
|
215
|
|
| Other Current Assets |
10
|
5
|
12
|
27
|
14
|
16
|
12
|
12
|
11
|
12
|
30
|
51
|
104
|
126
|
188
|
13
|
90
|
102
|
65
|
60
|
70
|
85
|
61
|
62
|
|
| Total Current Assets |
280
|
368
|
424
|
504
|
537
|
498
|
554
|
662
|
632
|
674
|
693
|
896
|
766
|
745
|
707
|
1 552
|
1 591
|
1 457
|
1 486
|
1 865
|
1 861
|
4 266
|
4 404
|
4 451
|
|
| PP&E Net |
201
|
199
|
201
|
289
|
275
|
253
|
251
|
263
|
235
|
247
|
220
|
225
|
214
|
222
|
214
|
213
|
199
|
201
|
197
|
183
|
192
|
192
|
195
|
260
|
|
| PP&E Gross |
201
|
199
|
201
|
289
|
275
|
253
|
251
|
263
|
235
|
247
|
220
|
225
|
214
|
222
|
214
|
213
|
199
|
201
|
197
|
183
|
192
|
192
|
195
|
260
|
|
| Accumulated Depreciation |
96
|
109
|
119
|
124
|
121
|
131
|
141
|
107
|
94
|
110
|
104
|
156
|
166
|
174
|
187
|
151
|
129
|
128
|
125
|
138
|
156
|
173
|
189
|
224
|
|
| Intangible Assets |
4
|
10
|
11
|
9
|
8
|
6
|
7
|
7
|
10
|
9
|
12
|
45
|
76
|
82
|
91
|
84
|
70
|
59
|
62
|
47
|
32
|
20
|
27
|
61
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
36
|
39
|
42
|
44
|
56
|
31
|
51
|
89
|
125
|
155
|
188
|
216
|
281
|
207
|
180
|
162
|
133
|
92
|
|
| Long-Term Investments |
17
|
18
|
27
|
25
|
36
|
36
|
37
|
43
|
43
|
22
|
25
|
25
|
18
|
22
|
17
|
17
|
85
|
299
|
308
|
480
|
528
|
523
|
549
|
515
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
4
|
5
|
8
|
9
|
13
|
8
|
11
|
18
|
67
|
176
|
183
|
190
|
208
|
232
|
78
|
83
|
99
|
89
|
91
|
|
| Total Assets |
502
N/A
|
595
+18%
|
663
+11%
|
827
+25%
|
855
+3%
|
798
-7%
|
889
+12%
|
1 022
+15%
|
970
-5%
|
1 009
+4%
|
1 014
+1%
|
1 232
+21%
|
1 143
-7%
|
1 227
+7%
|
1 330
+8%
|
2 203
+66%
|
2 322
+5%
|
2 439
+5%
|
2 566
+5%
|
2 860
+11%
|
2 876
+1%
|
5 263
+83%
|
5 396
+3%
|
5 470
+1%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
30
|
43
|
56
|
98
|
94
|
94
|
112
|
152
|
190
|
198
|
176
|
273
|
185
|
195
|
177
|
150
|
166
|
154
|
145
|
121
|
92
|
289
|
274
|
325
|
|
| Accrued Liabilities |
8
|
16
|
21
|
19
|
15
|
17
|
20
|
41
|
32
|
33
|
35
|
27
|
21
|
22
|
23
|
30
|
34
|
33
|
29
|
81
|
74
|
91
|
87
|
86
|
|
| Short-Term Debt |
74
|
102
|
102
|
172
|
219
|
176
|
230
|
279
|
126
|
111
|
142
|
134
|
141
|
208
|
230
|
36
|
85
|
93
|
99
|
97
|
102
|
27
|
24
|
30
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
24
|
32
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
6
|
5
|
7
|
|
| Other Current Liabilities |
30
|
41
|
28
|
26
|
51
|
37
|
35
|
36
|
53
|
59
|
36
|
105
|
95
|
85
|
148
|
92
|
109
|
106
|
81
|
150
|
56
|
79
|
135
|
87
|
|
| Total Current Liabilities |
142
|
201
|
207
|
339
|
411
|
328
|
397
|
508
|
400
|
402
|
388
|
538
|
442
|
509
|
577
|
309
|
393
|
387
|
355
|
448
|
328
|
492
|
526
|
535
|
|
| Long-Term Debt |
5
|
5
|
24
|
41
|
9
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
0
|
0
|
14
|
16
|
11
|
15
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Minority Interest |
9
|
20
|
20
|
24
|
5
|
5
|
6
|
7
|
8
|
8
|
7
|
8
|
9
|
11
|
13
|
65
|
57
|
53
|
95
|
97
|
107
|
105
|
109
|
110
|
|
| Other Liabilities |
2
|
3
|
8
|
8
|
8
|
11
|
12
|
8
|
8
|
15
|
11
|
20
|
23
|
35
|
38
|
33
|
23
|
31
|
28
|
32
|
30
|
44
|
38
|
43
|
|
| Total Liabilities |
158
N/A
|
229
+44%
|
259
+13%
|
413
+60%
|
432
+5%
|
349
-19%
|
419
+20%
|
526
+26%
|
420
-20%
|
429
+2%
|
410
-4%
|
570
+39%
|
478
-16%
|
559
+17%
|
632
+13%
|
411
-35%
|
477
+16%
|
475
-1%
|
477
+1%
|
577
+21%
|
480
-17%
|
657
+37%
|
685
+4%
|
703
+3%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
111
|
111
|
111
|
144
|
144
|
144
|
144
|
217
|
217
|
217
|
217
|
217
|
217
|
217
|
217
|
386
|
541
|
541
|
541
|
541
|
541
|
703
|
703
|
703
|
|
| Retained Earnings |
56
|
78
|
112
|
110
|
116
|
142
|
163
|
159
|
215
|
244
|
269
|
303
|
336
|
338
|
370
|
429
|
480
|
607
|
717
|
911
|
1 024
|
1 129
|
1 233
|
1 299
|
|
| Additional Paid In Capital |
177
|
177
|
180
|
159
|
163
|
163
|
163
|
120
|
120
|
119
|
119
|
142
|
113
|
113
|
113
|
977
|
822
|
822
|
883
|
883
|
883
|
2 775
|
2 778
|
2 770
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
51
|
51
|
51
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
5
|
1
|
2
|
1
|
2
|
3
|
5
|
|
| Total Equity |
344
N/A
|
367
+7%
|
404
+10%
|
414
+2%
|
423
+2%
|
449
+6%
|
470
+5%
|
495
+5%
|
551
+11%
|
580
+5%
|
604
+4%
|
662
+10%
|
666
+1%
|
668
+0%
|
699
+5%
|
1 792
+157%
|
1 844
+3%
|
1 965
+7%
|
2 089
+6%
|
2 283
+9%
|
2 396
+5%
|
4 605
+92%
|
4 711
+2%
|
4 768
+1%
|
|
| Total Liabilities & Equity |
502
N/A
|
595
+18%
|
663
+11%
|
827
+25%
|
855
+3%
|
798
-7%
|
889
+12%
|
1 022
+15%
|
970
-5%
|
1 009
+4%
|
1 014
+1%
|
1 232
+21%
|
1 143
-7%
|
1 227
+7%
|
1 330
+8%
|
2 203
+66%
|
2 322
+5%
|
2 439
+5%
|
2 566
+5%
|
2 860
+11%
|
2 876
+1%
|
5 263
+83%
|
5 396
+3%
|
5 470
+1%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
485
|
485
|
485
|
485
|
485
|
485
|
485
|
485
|
485
|
485
|
485
|
485
|
485
|
485
|
485
|
541
|
541
|
541
|
541
|
541
|
536
|
703
|
703
|
703
|
|